Navigation Links
FDA Grants Astellas Qualified Infectious Disease Product Designation for Isavuconazole for the Treatment of Invasive Aspergillosis
Date:12/3/2013

. Isavuconazole demonstrated non-inferiority versus voriconazole. Isavuconazole was effective as determined by the primary endpoint of all-cause mortality through day 42 in the intent-to-treat population (N=516). Study drug-related adverse events were reported in 42.4% of the isavuconazole and 59.8% of the voriconazole treatment group. Overall drug- and non-drug-related adverse events were reported in 96.1% and 98.5% of patients in the isavuconazole and voriconazole treatment groups, respectively.

The VITAL study is an open-label phase 3 study including patients with invasive fungal disease caused by emerging fungal pathogens such as Zygomycetes and patients with aspergillosis and pre-existing renal impairment. Enrollment into VITAL has been completed (N=150). Based on the investigator reported data, approximately 45 patients were enrolled with zygomycosis and a similar number of patients were enrolled with pre-existing renal impairment. Review of diagnosis and outcomes by an Independent Data Review Committee is ongoing.

The phase 3 ACTIVE study is a randomized, double-blind study evaluating the use of isavuconazole i.v. and oral versus caspofungin i.v. followed by oral voriconazole for the treatment of invasive Candida infections. The ACTIVE study continues to recruit with anticipated completion of enrollment in the first part of 2015.

About Astellas
Astellas Pharma US, Inc., located in Northbrook, Illinois, is a US affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The organization is committed to becoming a global category leader in focused areas by combining outstanding R&D and marketing capabilities. For more information about Astellas Pharma US, Inc., please visit our website at ww
'/>"/>

SOURCE Astellas Pharma US, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. RadSite Grants Accreditation to First Wave of MIPPA Program Applicants
2. NASDAQ Grants China Jo-Jo Drugstores 180-Day Extension to Regain Compliance with Bid Price Requirement
3. U.S. FDA Grants Orphan Drug Designation for KaloBios KB001-A in Treatment of Cystic Fibrosis Patients
4. FDA Grants 510(k) Clearance for Innovative Fuse Gastroscope from EndoChoice
5. Philanthropic Grants, Product Launches, Promising Partnerships, and Customer Satisfaction Rankings - Research Report on CVS Caremark, Walgreens, McKesson, AmerisourceBergen, and Cardinal Health
6. Life Technologies Awards Digital PCR Innovation Grants to Five Research Labs
7. FDA Grants Lillys Ramucirumab Priority Review as a Potential Single-Agent Treatment for Advanced Gastric Cancer
8. FDA Grants Orphan Drug Designation to Omeros OMS824 for Huntingtons Disease
9. European Union Grants a Good Manufacturing Practice Certificate to Nelson Laboratories
10. The Kenneth Rainin Foundation Continues its Commitment to Ending Inflammatory Bowel Disease, Awarding $1.5 Million in Research Grants
11. FDA Grants Orphan Drug Status To Eisais Investigational Compound (E7777) For Cutaneous T-Cell Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... 1, 2015 Taiwan,s ... conference in Taipei on  August ... Vaucarrin™ platform, a targeted drug delivery technology that uses ... This event was part of a joint press conference held ... Inc. (GNT), showcasing GNT,s latest edible gold-based food and ...
(Date:9/1/2015)... 1, 2015 The global ... basis of sectors, products & services and application. And ... with the increasing demand of advanced drugs for ... propel the growth for bioinformatics market. The implementation ... is known as bioinformatics. Decreasing cost of DNA ...
(Date:9/1/2015)... 31, 2015 Research and Markets ( ... "Introduction to Veterinary Pharmacovigilance (London, UK - ... This course has been designed to ... those concerned with Veterinary Pharmacovigilance. New entrants, support ... a better understanding of veterinay drug safety will ...
Breaking Medicine Technology:GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 2GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 3GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 4GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 5Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 2Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 3Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 4Introduction to Veterinary Pharmacovigilance Seminar (London, UK - September 23-24) 2
... 10 BioMosaics Inc., a cancer,biomarker development company, ... its proprietary products for the identification of Glypican-3,(GPC3) ... vitro diagnostic tests. This will,allow the GPC3 (Human ... or plasma, and the GPC3 (Human Glypican-3) Monoclonal ...
... Peregrine,Pharmaceuticals, Inc. (Nasdaq: PPHM ), a clinical ... of cancer and,hepatitis C virus (HCV) infection, today ... the Drug Controller General of India (DCGI) for ... of bavituximab in combination,with the chemotherapy drugs paclitaxel ...
Cached Medicine Technology:BioMosaics' Glypican-3 Blood & Tissue Tests Receive CE Marking in Europe 2Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 2Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 3Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 4
(Date:9/2/2015)... ... September 02, 2015 , ... Available in select spas ... PIONNIÈRE XMF Perfection Youth Rich Cream , an evolution of the classic ... with a lipid-replenishing marine oil for intense nourishing and moisturizing. Phytomer exclusive ingredient ...
(Date:9/2/2015)... ... 02, 2015 , ... Canopy Partners, a North Carolina based ... 5000 List, an independent ranking of the fastest- growing private companies in ... achievement puts Canopy in rarefied company. Over the years, this elite group has ...
(Date:9/2/2015)... ... September 02, 2015 , ... Traveling to the Caribbean can be an ... flora and fauna. , Lifestyle Holidays Vacation Club knows that Puerto ... travelers experience that much better, Lifestyle Holidays Vacation Club has put together its list ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... September is ... this disease that affects more than 233,000 men each year in the United States. ... the most common non-skin cancer in America, affecting 1 in 7 men. One new ...
(Date:9/1/2015)... ... September 01, 2015 , ... Earth Brands, ... new fall collection. Every customer who buys an Earth Brand shoe will be ... partnership with Trees for the Future, a nonprofit dedicated to planting more trees. ...
Breaking Medicine News(10 mins):Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 2Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 4Health News:Canopy Partners Named to 2015 Inc. 5000 Fastest Growing Companies List 2Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 2Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 3Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 3
... 12, 2011Michael L. Dennis, Ph.D., Senior Research Psychologist ... Christy K. Scott, Ph.D., Research Psychologist at the ... Anderson Research Award for their long-term outcomes study ... treatment outcomes among adults attending alcohol/drug treatment. Sponsored ...
... Public Images: Cut and paste into the body of ... search to date of DNA abnormalities in chronic lymphocytic ... drive this common blood cancer, a finding that could ... will progress rapidly or remain indolent for years, say ...
... Medical researchers at the University of Alberta have created ... and informational topics related to weight, that parents can ... child,s weight management with health professionals. Researchers in ... of Alberta created these ,conversation cards, based on their ...
... multiforme (GBM) is the most common and lethal of ... For most patients, treatment involves surgery followed by both ... are resistant to the effects of temozolomide. A team ... of Toronto, Toronto, has now determined that the protein ...
... brain atrophy patterns in Alzheimer,s disease patients using MRIs ... to a new study by researchers from the Perelman ... also found that higher baseline Alzheimer,s patterns of atrophy ... The study is published online in Brain . ...
... be part of the Homo erectus diet. But the ... survival of Homo erectus and the evolution of modern ... Tel Aviv University researchers Dr. Ran Barkai, Miki Ben-Dor, and Prof. ... Studies examined the published data describing animal bones associated with ...
Cached Medicine News:Health News:Drs. Michael Dennis and Christy Scott earn Hazelden’s Dan Anderson Research Award 2Health News:Drs. Michael Dennis and Christy Scott earn Hazelden’s Dan Anderson Research Award 3Health News:Massive DNA search uncovers new mutations driving blood cancer 2Health News:Massive DNA search uncovers new mutations driving blood cancer 3Health News:Researchers develop 'conversation cards' to broach subject of pediatric weight management 2Health News:Researchers develop 'conversation cards' to broach subject of pediatric weight management 3Health News:Test for Alzheimer's disease predicts cognitive decline in Parkinson's disease 2Health News:The disappearance of the elephant caused the rise of modern man 2Health News:The disappearance of the elephant caused the rise of modern man 3
... to dilate the lower ureter ... assess possible submucosal tunneling. Also ... anesthetic in the ureter. The ... or dislodgment of a ureteral ...
... Used for the injection of contrast medium, ... dual lumen design eliminates the need for ... to promote atraumatic passage into and through ... of hydrophilic polymer that when activated, attracts ...
Used for retrograde pyelogram. Supplied sterile in peel-open packages. Intended for one-time use....
Used for drainage and navigation of a tortuous ureter. The tapered tip eases placement as there are no edges to interfere with the ureteral orifice. Supplied sterile in peel-open packages. Intended f...
Medicine Products: